AMN Stock Recent News

AMN Healthcare's dismal results in the majority of its segments led to a soft overall fourth-quarter performance.

AMN Healthcare Services, Inc. (NYSE:AMN ) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Company Participants Randall Reese - Senior Director of Investor Relations and Strategy Cary Grace - President and Chief Executive Officer Brian Scott - Chief Financial Officer and Chief Operating Officer Conference Call Participants Jasper Bibb - Truist Securities, Inc. A.J. Rice - UBS Investment Bank Jeffrey Silber - BMO Capital Markets Joanna Gajuk - Bank of America Merrill Lynch Mark Marcon - Robert W.

Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

AMN Healthcare Services (AMN) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $1.32 per share a year ago.

Quarterly revenue of $735 million; GAAP loss of ($4.90)/share and adjusted EPS of $0.75

Here is a sneak peek into how three MedTech stocks, GKOS, ITGR and AMN, are expected to fare in their quarterly results, slated to be released tomorrow.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for AMN Healthcare (AMN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.

DALLAS, Jan. 23, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its fourth quarter and full year 2024 financial results and first quarter 2025 outlook on Thursday, February 20, 2025, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time.

Shares have tumbled to new 5-year lows.

AMN Healthcare is rated a buy due to its historically low valuation and strong long-term prospects in the healthcare staffing industry. Despite recent revenue declines post-pandemic, the long-term demand for healthcare services and staffing is expected to grow significantly, benefiting AMN Healthcare. The company leverages advanced technology to streamline recruitment processes, enhancing its competitive edge and making it a valuable partner for healthcare providers.